HITIQ (ASX: HIQ) is a technology company that provides a transformative, end-to-end concussion management platform.
The company recently received its $2,180,805 Research & Development Tax Incentive (RDTI) for the year ended 30 June 2022, which was in line with the company's estimate.
HITIQ is targeting a growing worldwide concussion management market, including elite and recreational sports, clinical practitioners, military, research, and combat sports, with a market opportunity estimated to be around 10 million people.
Following the announcement, shares of Hitiq (ASX:HIQ) were down 6%.